List of Studies
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFTCAPS)
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Apolipoprotein Related Mortality Risk Study (AMORIS)
Atherosclerosis Risk in Communities Study (ARIC)
ATTICA Study (ATTICA)
Australian Diabetes, Obesity and Lifestyle Study (AUSDIAB)
Bezafibrate Infarction Prevention Registry Study (BIP)
British Regional Heart Study (BRHS)
British Women’s Heart and Health Study (BWHHS)
Bruneck Study (BRUN)
British Union Provident Association Study (BUPA)
Busselton Health Study (BHS)
Caerphilly Prospective Study (CaPS)
Cardiovascular Health Study (CHS)
Cardiovascular Study in the Elderly (CASTEL)
Charleston Heart Study (CHARL)
Chicago Heart Association Study (CHA)
Cohort of Norway (CONOR)
Copenhagen City Heart Study (COPEN)
Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR)
Diet and Risk of Cardiovascular Disease in Spain (DRECE)
Dubbo Study of the Elderly (DUBBO)
Edinburgh Artery Study (EAS)
Epidemiologische Studie zu Chancen der Verhütung (ESTHER)
Established Populations for the Epidemiologic Study of the Elderly – East Boston (EPESEBOS)
Established Populations for the Epidemiologic Study of the Elderly – Iowa (EPESEIOW)
Established Populations for the Epidemiologic Study of the Elderly – North Carolina (EPESENCA)
Established Populations for the Epidemiologic Study of the Elderly – New Haven (EPESENHA)
European Prospective Investigation of Cancer Norfolk Study (EPIC/EPICNOR)
Finland, Italy and Netherlands Elderly Study – Finnish cohort (FINE_FIN)
Finland, Italy and Netherlands Elderly Study – Italian cohort (FINE_IT)
Finrisk Cohort 1992 (FINRISK92)
Finrisk Cohort 1997 (FINRISK97)
First Myocardial Infarction in Northern Sweden (FIA)
Fletcher Challenge Blood Study (FLETCHER)
Framingham Offspring Study (FRAMOFF)
Funagata Study (FUNAGATA)
Glostrup Study (GLOSTRUP)
Glucose Intolerance, Obesity and Hypertension Study (GOH)
Göteborg 1913 Study (GOTO13)
Göteborg 1933 Study (GOTO33)
Göteborg 1943 Study (GOTO43)
Göttingen Risk Incidence and Prevalence Study (GRIPS)
Health Professionals Follow-up Study (HPFS)
Helsinki Aging Study (HELSINAG)
Helsinki Businessmen Study (HBS)
Hertfordshire Cohort Study (HCS)
Health in Men Study (HIMS)
Hisayama Study (HISAYAMA)
Honolulu Heart Program (HONOL)
Hoorn Study (HOORN)
Ikawa, Kyowa, Noichi Study (IKNS)
Israeli Ischaemic Heart Disease Study (ISRAEL)
Kuopio Ischaemic Heart Disease Study (KIHD)
Longitudinal Aging Study Amsterdam (LASA)
Lower Extremity Arterial Disease Event Reduction Trial (LEADER)
Malmö Diet and Cancer Study (MDC)
Malmö Preventive Project (MPP/MALMO)
MESA Study
The MIDSPAN studies (MIDSPAN)
MONICA/KORA Augsburg Survey 1 (MOGERAUG1/MONICA/KORA1)
MONICA/KORA Augsburg Survey 2 (MOGERAUG2/MONIKA/KORA2)
MONICA/KORA Augsburg Survey 3 (MOGERAUG3/MONIKA/KORA3)
MONICA Göteborg Study (MOSWEGOT)
Monitoring of CVD Risk Factors Project (MCVDRFP)
Multi-Ethnic Study of Atherosclerosis (MESA)
Multiple Risk Factor Intervention Trial (MRFIT)
National Health and Nutrition Examination Survey (NHANESI)
National Health and Nutrition Examination Survey (NHANESII)
National Health and Nutrition Examination Survey (NHANESIII)
Monitoring Project on Chronic Disease Risk Factors (MORGEN)
North Karelia Project (KAREL72/KARELIA/North Karelia)
Northwick Park Heart Study I (NPHSI)
Northwick Park Heart Study II (NPHSII)
Norwegian Counties Study (NCS)
Nova Scotia Health Survey (NSHS)
Nurses Health Study (NHS)
Osaka Study (OSAKA)
Oslo Study (OSLO)
Oyabe Study (OYABE)
Paris Prospective Study I (PARIS1)
Population Study of Women in Göteborg (GOTOW)
Prevention of Renal and Vascular End Stage Disease Study (PREVEND)
Progetto CUORE (CUORE)
Prospect EPIC (EPICPRO / UTRECHT)
Prospective Cardiovascular Münster Study (PROCAM)
Prospective Epidemiological Study of Myocardial Infarction (PRIME)
Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
Puerto Rico Heart Health Program (PRHHP)
Quebec Cardiovascular Study (QUEBEC)
Rancho Bernardo Study (RANCHO)
Reykjavik Study (REYK)
Risk Factors and Life Expectancy Pooling Project (RIFLE)
Rotterdam Study (ROTT/RS-I)
Rotterdam Study II (RS-II)
Rotterdam Study III (RS-III)
Scottish Heart Health Extended Cohort (SHHEC)
Study of Health in Pomerani (SHIP)
Speedwell Study (SPEED)
Strong Heart Study† (SHS)
Established Populations for the Epidemiologic Study of the Elderly Studies (MRCOLD)
Thrombosis Prevention Trial (TPT)
Toyama Study (TOYAMA)
Tromsø Study (TROMSO)
Turkish Adult Risk Factor Study (TARFS)
U.S. Physicians Health Study (USPHS)
U.S. Physicians Health Study 2 (USPHS2)
US Railroad (USRAIL)
Uppsala Longitudinal Study of Adult Men (ULSAM)
Vicenza Thrombophilia and Athrosclerosis Project (VITA)
Vorarlberg Health Monitoring and Promotion Programme (VHMPP)
West of Scotland Coronary Prevention Study (WOSCOPS)
Whitehall I Study (WHITEI)
Whitehall II Study (WHITEII)
Women’s Health Initiative (Hormones and Biomarkers Predicting Stroke in Women) (WHI/WHIHABPS)
Women’s Health Initiative (Observational Study) (WHIOS)
Women’s Health Study (WHS)
Wüerttemberg Constructions Workers Cohort (WCWC)
Xi’an Cohort Study (XIAN)
Zaragoza study (ZARAGOZA)
Zutphen Elderly Study (ZUTE)
† SHS: The opinions expressed in this paper are those of the author(s) and do not necessarily reflect the views of the Indian Health Service, IHS.
Funding sources
The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The Atherosclerosis Risk in Communities Study was provided the reagents and loan of a BNII instrument by Siemens Healthcare Diagnostics to conduct the CRP assays.”
The British Women’s Heart and Health Study (BWHHS) is supported by the British Heart Foundation (PG/13/66/30442). Data on mortality and cancer events were routinely provided from NHS Digital to the BWHHS under data sharing agreement MR104a- Regional Heart Study (Female Cohort). British Women’s Heart and Health Study data are available to bona fide researchers for research purposes. Please refer to the BWHHS data sharing policy at http://www.ucl.ac.uk/british-womens-heart-health-study.
The Caerphilly Prospective Study was undertaken by the former UK Medical Research Council Epidemiology Unit (South Wales) and was funded by the MRC; its data archive is maintained by the Department of Social Medicine, University of Bristol.
The Charleston Heart Study was supported by Award Number UL1RR029882 from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the National Institutes of Health.
The Cardiovascular Health Study (CHS) is supported by contracts HHSN268201200036C, HHSN268200800007C, N01 HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086 and NHLBI grant HL080295, with additional contribution from NINDS. Additional support was provided through AG-023629 from the NIA. See also https://chs-nhlbi.org/pi. This manuscript has been reviewed by CHS for scientific content and consistency of data interpretation with previous CHS publications.”
The Established Populations for the Epidemiologic Study of the Elderly – North Carolina (EPESENCA) study was supported by grant from the National Institute on Aging at the National Institutes of Health (contract number N01-AG12102, research
grant number R01 AG12765).
The ESTHER study (Epidemiologische Studie zu Chancen der Verhütung) was funded by grants from the State Ministry of Research, Science and Arts Baden-Württemberg and the German Federal Ministries of Education and Research and of Family, Senior Citizens, Women and Youth
The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). ERFC manuscripts have been reviewed by Framingham Heart Study Investigators for scientific content and consistency of data interpretation with previous Framingham Heart Study publications.
The KORA research platform and the MONICA Augsberg studies were initiated and financed by the GSF-National Research Centre for Environment and Health, which is funded by the German Federal Ministry of Education and Research and by the state of Bavaria.
The MESA study was supported by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute and by grants UL1-TR-000040 and UL1-TR-001079 from NCRR. We thank the MESA investigators, the staff, and the participants of the MESA study for their valuable contributions. A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.
The Nova Scotia Health Survey was supported financially by the National Heart, Lung, and Blood Institute Grants HL-0806665, HL-076857, HL-088117 and HL-084034.
The Whitehall II study has been supported by grants from the Medical Research Council; British Heart Foundation; National Heart Lung and Blood Institute, US, NIH: and National Institute on aging, US, NIH.